These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37803297)

  • 21. EZH2 Protein Expression and Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Neusquen LP; Filassi JR; Fristachi CE; Carvalho KC; Dória MT; Soares Júnior JM; Piato JR
    Rev Bras Ginecol Obstet; 2016 Jun; 38(6):280-6. PubMed ID: 27399922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
    Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression.
    Pang J; Toy KA; Griffith KA; Awuah B; Quayson S; Newman LA; Kleer CG
    Breast Cancer Res Treat; 2012 Aug; 135(1):59-66. PubMed ID: 22527102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of EZH2 in breast cancer and its clinicopathological significance].
    Liu J; Wang H; Deng Y; Cao P; Li X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 42(4):443-9. PubMed ID: 24022934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.
    Liu J; Xu C; Xu D; Cao L; Xue H; Meng Q; Niu Y
    Virchows Arch; 2020 Aug; 477(2):279-289. PubMed ID: 32086588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.
    Gonzalez ME; DuPrie ML; Krueger H; Merajver SD; Ventura AC; Toy KA; Kleer CG
    Cancer Res; 2011 Mar; 71(6):2360-70. PubMed ID: 21406404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
    Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active transport of RB protein from the nucleus to the cytoplasm as one of the development mechanisms of HER2-positive breast cancer.
    Kowalik A; Kopczyński J; Wypiórkiewicz E; Góźdź S; Meżyk R; Siedlecki JA
    Pol J Pathol; 2013 Apr; 64(1):9-14. PubMed ID: 23625594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neratinib for HER2-positive breast cancer with an overlooked option.
    Guo L; Shao W; Zhou C; Yang H; Yang L; Cai Q; Wang J; Shi Y; Huang L; Zhang J
    Mol Med; 2023 Oct; 29(1):134. PubMed ID: 37803271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
    Frogne T; Laenkholm AV; Lyng MB; Henriksen KL; Lykkesfeldt AE
    Breast Cancer Res; 2009; 11(1):R11. PubMed ID: 19239686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.
    Alford SH; Toy K; Merajver SD; Kleer CG
    Breast Cancer Res Treat; 2012 Apr; 132(2):429-37. PubMed ID: 21614565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
    Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
    Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer.
    Nouruzi S; Tabrizian N; Zoubeidi A
    Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36718085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EZH2-CCF-cGAS Axis Promotes Breast Cancer Metastasis.
    Duan D; Shang M; Han Y; Liu J; Liu J; Kong SH; Hou J; Huang B; Lu J; Zhang Y
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EZH2 expression in invasive lobular carcinoma of the breast.
    Roh S; Park SY; Ko HS; Sohn JS; Cha EJ
    World J Surg Oncol; 2013 Nov; 11():299. PubMed ID: 24266940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
    Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
    Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer.
    Jang SH; Lee JE; Oh MH; Lee JH; Cho HD; Kim KJ; Kim SY; Han SW; Kim HJ; Bae SB; Lee HJ
    J Breast Cancer; 2016 Mar; 19(1):53-60. PubMed ID: 27066096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.
    Zhang J; Yin YT; Wu CH; Qiu RL; Jiang WJ; Deng XG; Li ZX
    Dis Markers; 2019; 2019():8186091. PubMed ID: 31827645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.